[Obesity: ectopic fat distribution and the heart].
The metabolic syndrome is usually associated with insulin resistance and visceral fat distribution, which appear to play a direct role in the development of clinical criteria of metabolic syndrome, like elevation of arterial blood pressure and dyslipidemia. In this review, the authors will first introduce the concept, that insulin resistance and increased visceral adipose tissue are also regularly associated with an abnormal or ectopic accumulation of lipids in nonadipocytes, like steatosis hepatis. Then, they will provide some evidence that epicardial fat can be associated with insulin resistance in a similar fashion as visceral intraabdominal fat. Furthermore, epicardial fat might directly affect the vessels and function of the heart. Accordingly, ectopic accumulation of fat within cardiac muscle cells can impair their function and possibly be related to heart failure. These new relations between obesity, fat distribution and cardiac function might help to identify and treat individuals at risk earlier and more appropriately.
Müller-Wieland
Dirk
D
Abteilung für Allgemeine Innere Medizin, Gastroenterologie, Endokrinologie, Diabetes und Stoffwechsel, Institut für diabetologische Versorgungsforschung, Asklepios Klinik St. Georg, Hamburg, Germany. d.mueller-wieland@asklepios.com
Knebel
Birgit
B
Haas
Jutta
J
Merkel
Martin
M
Kotzka
Jörg
J
D000273:Adipose Tissue / Q000503:physiopathology*; D002828:Choristoma / Q000503:physiopathology*; D006321:Heart / Q000503:physiopathology*; D006801:Humans; D008955:Models, Cardiovascular; D009765:Obesity / Q000503:physiopathology*
Annu Rev Med. 2002;53:319-36
11818477
J Appl Physiol (1985). 2009 Jan;106(1):5-11
18927266
Obes Rev. 2007 May;8(3):253-61
17444966
Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):536-43
16186852
Physiol Rev. 2007 Apr;87(2):507-20
17429039
J Clin Invest. 2008 Feb;118(2):421-8
18246192
J Clin Endocrinol Metab. 2006 Nov;91(11):4689-95
16926257
Circulation. 2009 Mar 31;119(12):1586-91
19289634
Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38
17690317
World J Gastroenterol. 2008 Apr 28;14(16):2474-86
18442193
Am Heart J. 2007 Jun;153(6):907-17
17540190
Diabetes. 2003 Dec;52(12):2882-7
14633847
Endocr Rev. 2008 Dec;29(7):777-822
18971485
Endocr Rev. 2008 Dec;29(7):939-60
18723451
Biochim Biophys Acta. 2010 Mar;1801(3):209-14
19948243
Diabetes. 2002 Dec;51 Suppl 3:S405-13
12475783
Ann Intern Med. 2006 Apr 4;144(7):517-24
16585666
J Lipid Res. 2009 Apr;50 Suppl:S15-27
18974038
Circ Res. 2007 Oct 12;101(8):759-67
17932333
Arch Intern Med. 2010 Mar 8;170(5):478-84
20212186
Circulation. 2009 Oct 20;120(16):1640-5
19805654
Am J Clin Nutr. 2009 Sep;90(3):499-504
19571212
Obesity (Silver Spring). 2009 Apr;17(4):625; author reply 626-7
19322142
J Clin Endocrinol Metab. 2009 Nov;94(11):4472-82
19820028
Circulation. 2008 Feb 5;117(5):605-13
18212276
Circulation. 2004 Jan 27;109(3):433-8
14744958
Diabetes. 2002 Jan;51(1):7-18
11756317
Hypertension. 2008 Feb;51(2):282-8
18172058
Hypertension. 1995 Jul;26(1):193-8
7607723
Circulation. 2007 Sep 4;116(10):1170-5
17698735
Int J Obes (Lond). 2010 Jun;34(6):949-59
20065965
Expert Opin Ther Targets. 2004 Apr;8(2):141-9
15102555
Cell. 2010 Jan 8;140(1):148-60
20074523